The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,359K data for 631K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

44 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

Article Title
Synthesis and biological evaluation of novel flavanone derivatives as potential antipsychotic agents.BDB
Key Laboratory For Neurodegenerative Diseases of Ministry of Education
Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.BDB
University of Sargodha
Steady-state kinetic mechanism of Ras farnesyl:protein transferase.BDB
Merck Research Laboratories
Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.BDB
Creighton University
Rabbit cerebral cortex 5HT1a receptors.BDB
University of Montana
Alpha-1 adrenergic receptor binding in aortas from rat and dog: comparison of [3H]prazosin and beta-iodo-[125I]-4-hydroxyphenyl-ethyl-aminomethyl-tetralone.BDB
Unwersity of Misscuri
Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.BDB
Universita Degli Studi Di Firenze
Aromatic organic compounds as scaffolds for metallocarboxypeptidase inhibitor design.BDB
Universitat AutÒnoma De Barcelona
Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury.BDB
Dainippon Sumitomo Pharma
Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.BDB
University of Konstanz
Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.BDB
Boehringer Ingelheim Pharmaceuticals
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.BDB
Dupont Pharmaceuticals
Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability.BDB